Oleoylethanolamide: A Novel Potential Pharmacological Alternative to Cannabinoid Antagonists for the Control of Appetite

The initial pharmaceutical interest for the endocannabinoid system as a target for antiobesity therapies has been restricted by the severe adverse effects of the CB1 antagonist rimonabant. This study points at oleoylethanolamide (OEA), a monounsaturated analogue, and functional antagonist of anandam...

Descripción completa

Detalles Bibliográficos
Autores principales: Romano, Adele, Coccurello, Roberto, Giacovazzo, Giacomo, Bedse, Gaurav, Moles, Anna, Gaetani, Silvana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996326/
https://www.ncbi.nlm.nih.gov/pubmed/24800213
http://dx.doi.org/10.1155/2014/203425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996326/
https://www.ncbi.nlm.nih.gov/pubmed/24800213
http://dx.doi.org/10.1155/2014/203425

Ejemplares similares